par Piccart-Gebhart, Martine
;Floquet, A;Scarfone, G;Willemse, P H B;Emerich, J;Vergote, Ignace;Giurgea, L;Coens, C;Awada, Ahmad
;Vermorken, Jan Baptist
Référence International journal of gynecological cancer, 13 Suppl 2, page (196-203)
Publication Publié, 2003


Référence International journal of gynecological cancer, 13 Suppl 2, page (196-203)
Publication Publié, 2003
Article révisé par les pairs
Titre: |
|
Auteur: | Piccart-Gebhart, Martine; Floquet, A; Scarfone, G; Willemse, P H B; Emerich, J; Vergote, Ignace; Giurgea, L; Coens, C; Awada, Ahmad; Vermorken, Jan Baptist |
Informations sur la publication: | International journal of gynecological cancer, 13 Suppl 2, page (196-203) |
Statut de publication: | Publié, 2003 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents -- administration & dosage | |
Cisplatin -- administration & dosage | |
Disease-Free Survival | |
Europe | |
Female | |
Humans | |
Infusions, Intravenous | |
Injections, Intraperitoneal | |
Middle Aged | |
Ovarian Neoplasms -- drug therapy | |
Ovarian Neoplasms -- mortality | |
Ovarian Neoplasms -- pathology | |
Ovarian Neoplasms -- surgery | |
Survival Analysis | |
Treatment Outcome | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Langue: | Anglais |
Identificateurs: | urn:issn:1048-891X |
info:pii/13360 | |
info:pmid/14656280 |